The French Health Ministry announces approval of mifepristone combined with a prostaglandin for early medical abortion. But later in the year, Roussel Uclaf responds to protests from antiabortion groups and decides to suspend marketing mifepristone. 1988 Mifepristone is approved in China. 1989 Mifepristone becomes available in France. Mifepristone is approved for use in the United Kingdom.
Mifepristone is approved for use in Sweden.
Roussel Uclaf gives the Population Council U.S. rights to mifepristone. The Population Council begins humanclinical trials of mifepristone in the United States. 1995 U.S. human trials end with 2,121 women having obtained mifepristone abortions. The Population Council applies to the FDA for approval of mifepristone in March. An FDA advisory committee recommends FDA approval in July.